HealthLynked Corp. (HLYK) intrinsic value & 10-year financials
HealthLynked Corp. (HLYK) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 0.7% a year to $2.1M, with an average return on invested capital of 241.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.10
- Market cap
- $6.0M
- Revenue (FY2025)
- $2.1M
- Revenue growth (10-yr CAGR)
- 0.7%
- ROIC (10-yr avg)
- 241.5%
- Free cash flow (FY2025)
- —
HLYK 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.1M | -$3.3M | -$1.16 | — | -102.3% | 74.1% |
| FY2024 | $3.0M | -$6.1M | -$0.02 | -$3.5M | -155.5% | 652.0% |
| FY2023 | $5.7M | -$1.0M | $0.00 | -$4.1M | -72.6% | -121.5% |
| FY2022 | $5.4M | -$8.8M | -$0.04 | -$4.4M | -160.1% | -336.7% |
| FY2021 | $5.8M | -$10.4M | -$0.05 | -$3.8M | -87.5% | -300.0% |
| FY2020 | $4.7M | -$5.8M | -$0.04 | -$2.1M | -64.8% | 1716.6% |
| FY2019 | $4.0M | -$5.5M | -$0.06 | -$2.4M | -79.8% | 186.1% |
| FY2018 | $2.3M | -$5.8M | -$0.07 | -$2.4M | -131.6% | 225.0% |
| FY2017 | $2.1M | -$2.6M | -$0.04 | -$1.6M | -85.2% | 171.5% |
| FY2016 | $1.9M | -$1.4M | -$0.02 | -$769.0K | -60.4% | 147.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
HealthLynked Corp has demonstrated mature, steady growth, with revenue compounding at 0.7% annually over the past decade.
HealthLynked Corp returns on capital have been average, hovering around 12.4% ROIC over the decade.
Over the decade, HealthLynked Corp shows that management has aggressively returned capital to shareholders by retiring 95.3% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, HealthLynked Corp is modeled at 0.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-9.85 per share.